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ABSTRACT 
Aloe barbadensis juice extract has been reported to possess hypoglycaemic property but the effects of its 
use on kidney and liver functions in diabetic animals have not been well investigated. This study investigated 
some biochemical parameters in the liver and kidney of alloxan-induced diabetic rats treated with Aloe 
barbadensis juice extract. Alloxan-induced diabetic rats were administered orally with Aloe barbadensis juice 
extract for seven days after which some biochemical indices in the serum, liver and kidney were measured 
and compared with the control. Serum alkaline phosphatase (ALP), alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), urea and creatinine of untreated diabetic group and treated diabetic 
groups were significantly elevated when compared with the normal control group with no significant changes 
in the levels of the enzymes in the liver and kidney. There were no significant changes (p>0.05) in the serum 
levels of Na+ and K+ in untreated diabetic group and treated diabetic groups when compared with the 
normal control rats which are not diabetic. These results suggest that administration of aqueous extract of 
Aloe barbadensis to diabetic rats did not have any adverse effect on the liver and kidney functions in rats 
showing that the extract is not toxic to man. 
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INTRODUCTION 
Diabetes Mellitus is a complex metabolic disorder 
in which the pancreas produces insufficient 
amounts of insulin, or in which individual’s system 
fail to respond appropriately to insulin. In people 
with diabetes, glucose levels build up in the blood 
and urine, causing excessive urination, thirst, 
hunger, and problems with fat and protein 
metabolism (Kathleen, 1996). The disease is 
ranked seventh among the leading causes of 
death and third in terms of its complications and is 
a major health problem in developed and 
developing countries (Seidell, 2000). The number 
of diabetic patients is increasing globally because 
of diverse changes in diets in all cultures. It has 
been predicted that the number of diabetic 
patients will double from 143 million in 1997 to 
about 300 million by 2025 largely because of 
dietary intake and other lifestyle factors (Seidell, 
2000).  
 
In the developing countries where majority of 
diabetic patients cannot afford effective but 
expensive drugs, the use of medicinal plants 
becomes an alternative therapy. A wide range of 
medicinal plants have been used by various 
cultures to treat diabetes mellitus because of their 
hypoglycaemic properties. Some of these 
medicinal plants include Vernomia amygdalina 
(Olagunju et al., 1998), unripe fruit of Carica 
papaya (Oloyede, 2005) and Aloe barbadensis 
(Adesokan et al., 2006). 
 










Aloe barbadensis (common name: Aloe vera) 
belongs to a class of plants called xeropids which 
have the ability to close their stomata completely 
to avoid loss of water (Artherton, 1997). Aloe vera 
is the source of the herbal preparations; the aloe 
gel and aloe latex. The aloe latex is commonly 
referred to as ‘aloe juice’. The latex contains a 
series of glycosides known as anthraquinones 
(Tyler, 1994). The hypoglycaemic property of this 
extract has earlier been shown (Adesokan et al., 
2006). It is therefore imperative to investigate the 
effects of this medicinal plant on liver and kidney 
functions in diabetic rats so as to ascertain its 
safety. 
 
MATERIALS AND METHODS 
Preparation of Aloe barbadensis juice extract 
Aloe barbadensis plant was obtained from Sango 
area, Ilorin, Nigeria and identified at the 
Department of Biological Sciences, University of 
Ilorin, Nigeria. The leaves were washed 
thoroughly under a running tap water, after which 
they were cut open. The gel was scooped into a 
muslin cloth and then squeezed to obtain the 
juice. The extract was prepared daily for each 
administration over the seven days experimental 
period. 5.0mg/ml and 10mg/ml doses were 
prepared to deliver 500mg/kg and 1000mg/kg 
body weight concentrations respectively to rats 
daily. 
 
Handling of Experimental Animals and 
Grouping 
Twenty four male albino rats (Rattus novergicus) 
with average weight of 160g were obtained from 
the Animal Holding Unit of the Department of 
Biochemistry, University of Ilorin, Nigeria. The rats 
were kept in metabolic cages which were cleaned 
of metabolic waste twice a day. They were 
exposed to 12 hours each of natural daylight and 
darkness and given rat chow and water ad 
libitum. They were divided into four groups. Group 
A (normal control) were not induced with 
diabetes. Group B (diabetic control) were induced 
with diabetes but not treated with Aloe 
barbadensis. Groups C and D (diabetic test 
groups) were induced with diabetes and treated 
daily with 500mg/kg and 1000mg/kg body weight 
Aloe barbadensis juice extract respectively. 
Procedures followed in raising the animals are in 
accordance with the ethical standards laid down 
by the Ethical Committee of the College of Health  
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Sciences, University of Ilorin, Nigeria and 
permission was granted by the Institution to 
undergo the study. 
Induction of Diabetes 
Alloxan monohydrate (2, 4, 5, 6 tetraoxypyridine 
5, 6-dioxyuracil) was obtained from BDH 
Chemicals Poole England. Five percent solution 
of the drug was prepared and used to induce 
diabetes in rats by intraperitoneal injection at a 
dose of 150mg/kg body weight. This drug has 
been reported to act by selectively destroying the 
beta cells of the pancreas thereby, reducing 
insulin secretion (Weaver et al., 1978). Diabetes 
was confirmed in the rats by measurement of 
blood glucose which was elevated. 
 
Preparation of Serum and Tissue Homogenate 
Rats were anaesthetized with diethyl-ether vapour 
and blood was obtained by cardiac puncture. The 
blood was left to clot at room temperature for one 
hour and then put in a refrigerator for a further 
one hour. The serum was collected after 
centrifugation at 3000rpm for 5 minutes. This was 
kept at about 0OC and used within 12 hour of 
preparation. After bleeding, animals were quickly 
dissected, the liver and kidneys removed and 
rinsed in ice-cold 0.25M sucrose solution. The 
tissues were thereafter cut finely with sterile blade 
before being homogenized in ice-cold 0.25M 
sucrose solution (1:5 w/v). The homogenate was 
kept frozen overnight to ensure maximum release 
of the enzymes (Akanji and Ngaha, 1989). 
 
Enzymes Assay and Measurement of Serum 
Metabolites 
Alkaline phosphatase (EC. 3.1.3.1) activity was 
determined by the Para- Nitrophenyl phosphate 
(PNPP) method of Wright et al. (1972). Alanine 
aminotransferase (EC. 2.6.1.2), and aspartate 
aminotransferase (EC. 2.6.1.1) were assayed as 
described by Mohun and Cook (1957). Serum 
urea concentration was determined using the 
carbamidodiacetyl micro method of Veniamin and 
Varkirtzi-Lemonia (1970). Serum creatinine was 
determined by Jaffe reaction described by Tietz et 
al. (1994), while serum sodium and potassium 
ions were determined by flame photometry using 
the Jenway Clinical PFP7 Flame Photometer. 
Assay kits used were obtained from Quimica 
Clinical Applicada S.A. (QCA), Amposta Spain. All 
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Statistical Analysis 
Data was analyzed using Duncan multiple range 
test (Montgomery, 1976) following one-way 
analysis of variance (ANOVA). Differences at 
P<0.05 were considered significant. 
RESULTS 
Tables 1, 2 and 3 show the activities of ALP, ALT 
and AST respectively in the tissues and serum of 
the experimental animals. There were no 
significant changes (p>0.05) in the levels of ALP, 
ALT and AST in the liver and kidney of diabetic 
animals treated with plant extract (C and D) when 
compared with the non diabetic (A) and untreated 
diabetic group (B). However, the activities of the 





(B, C and D) were significantly higher (p<0.05) 
than the normal control group (A). Values 
obtained for the three diabetic groups were not 
significantly different from one another. 
Table 4 shows the serum concentrations of Na+, 
K+, urea and creatinine in the experimental rats at 
the end of seven days. There were no significant 
differences in Na+ and K+ levels of the control 
and diabetic groups. There was significant 
increase (p<0.05) in the serum urea and 
creatinine levels of the diabetic groups (B, C and 
D) when compared to the normal control group 
(A) as seen in Table 4. However, there were no 
significant differences in the values obtained for 
untreated diabetic group and treated diabetic 
groups.
Table 1: Activities of alkaline phosphatase (ALP) in the liver, kidney and serum of alloxan-induced 
diabetic rats treated with Aloe barbadensis juice extract (IU/L) 
 
Group Liver Kidney Serum 
A 58.80±10.47 704.00±70.57 65.80±5.60 
B 59.12±12.35 795.10±63.25 100.80±8.10 * 
C 67.60±9.24 691.00±68.25 102.80±6.40 * 
D 66.60±5.60 692.00±74.36 100.40±5.90 * 
Values are Mean ± SD, n=6.  
*Values are significantly different from the normal control group at (p<0.05) 
 
A = Non diabetic rats not treated with Aloe barbadensis juice extract 
B = Diabetic rats not treated with Aloe barbadensis juice extract 
C = Diabetic rats treated with 500mg/kg body weight Aloe barbadensis juice extract 
D = Diabetic rats treated with1000mg/kg body weight Aloe barbadensis juice extract 
 
Table 2: Activities of alanine aminotransferase (ALT) in the liver, kidney and serum of alloxan-
induced diabetic rats treated with Aloe barbadensis juice extract (IU/L) 
 
Group Liver Kidney Serum 
A 538.00±52.15 200.00±25.50 10.60±1.82 
B 545.34±51.57 210.40±30.20 33.40±4.30 * 
C 540.00±65.15 215.50±24.50 32.60±3.50 * 
D 546.10±50.25 220.40±28.80 34.50±4.20 * 
Values are Mean ± SD, n=6.  
*Values are significantly different from the normal control group at (p<0.05) 
 
DISCUSSION  
The fact that the levels of the enzymes were 
maintained in the liver and kidney in all groups of 
the rat 
 means that the administered extract has no 
membrane labilizing effect on these organs. 
Enzyme activities in the tissues are often used as 
‘marker’ to ascertain early toxic effects of 
administered foreign compounds to experimental 
animals (Akanji and Ngaha, 1989; Adesokan and 
Akanji, 2004). ALP is a membrane bound enzyme 
while ALT and AST are cytosolic enzymes. These 
enzymes are highly concentrated in the liver and 
kidney and are only found in the serum in 
significant quantities when the cell membrane 
becomes leaky and even completely ruptured 
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Table 3: Activities of aspartate aminotransferase (AST) in the liver, kidney and serum of alloxan-
induced diabetic rats treated with Aloe barbadensis juice extract (IU/L) 
 
Group Liver Kidney Serum 
A 1172.80±164.50 1276.00±204.70 121.20±2.28 
B 1282.50±212.80 1234.00±280.90 186.20±4.41 * 
C 1402.00±202.40 1358.00±265.50 188.40±3.96 * 
D 1300.00±164.90 1326.00±260.50 190.60±3.55 * 
Values are Mean ± SD, n=6.  
*Values are significantly different from the normal control group at (p<0.05) 
 
Table 4: Serum Na+, K+, urea and creatinine concentrations of alloxan-induced diabetic rats treated 
with Aloe barbadensis juice extract (mmol/L) 
 
Group Na+ K+ Urea Creatinine 
A 141.20±2.28 4.14±0.62 3.54±0.34 44.40±5.81 
B 142.20±4.41 4.72±0.49 12.60±1.20 * 88.50±8.20 * 
C 141.40±2.70 4.82±0.26 10.80±0.90 * 86.60±5.80 * 
D 141.20±3.96 4.62±0.55 11.80±0.80 * 88.20±5.60 * 
Values are Mean ± SD, n=6.  
*Values are significantly different from the normal control group at (p<0.05) 
 
A rise in serum level or decrease in tissue level of 
these intracellular enzymes is an index of damage 
to liver and kidney cells (Moss and Rosalki, 
1986). 
 
The observed increase in serum enzyme levels 
without concomitant alteration in the tissue levels 
of the enzymes implied that the serum elevation 
in the diabetic groups might be from other 
sources apart from the liver and the kidney. 
Parenteral administration of alloxan at a dose of 
150mg/kg body weight has been reported to 
cause oxidative damage to pancreatic beta cells 
in rats (Weaver et al., 1978). This increase might 
therefore arise from the damaged pancreatic cells 
caused by alloxan which was not reversed by 
Aloe barbadensis administration. The observed 
non alteration in serum electrolyte in animals 
treated with the extract compared with the control 
is an indication that the extract might not have 
altered renal function in the rats. Alteration in 
serum levels of Na+ and K+ has been associated 
with renal function impairment (Halpperin and 
Kamel, 1998; Orth and Ritz, 1998). 
 
The significant increase observed in the serum 
urea and creatinine of all diabetic groups might be 
due to increased synthesis from the damaged 
pancreatic cells caused by alloxan injection and 
not as a result of kidney damage from Aloe 
barbadensis administration. This is so because 
rats in group B which were not treated with the 




This study indicated that administration of Aloe 
barbadensis juice extract to alloxanized diabetic 
rats at the doses considered and the duration of 
administration did not have any adverse effects 
on the liver and kidney functions in rats. 
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